Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework

FDA announces new actions advancing the agency’s biosimilars policy framework

Home | Copyright 2008-2025 FoodandDrugRecall.org